Skip to contentP
Pulse Biosciences, Inc.
P
PLSEPulse Biosciences, Inc. Q3 2021 · 10-Q
Revenue$574.00K$574.00Kno prior Q3 2020 on file Net Income-$14.28M-$14.28MN/M vs Q3 2020 EPS Diluted-$0.48-$0.48N/M vs Q3 2020 Operating Income-$14,273,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$13,507,000N/M Margins · derivedOperating margin-2486.6%
Net margin-2488.2%
ended Sep 30, 2021 · filed Nov 15, 2021 · 46 d after period end